A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis. - Wikidata - awgldk - TriplyDB

A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis.

A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis.

http://www.wikidata.org/entity/Q44907394

about

Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis Herbal medicines for fatty liver diseases Herbal medicines for fatty liver diseases Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management Treatment of non-alcoholic fatty liver disease Measurement of the total antioxidant response using a novel automated method in subjects with nonalcoholic steatohepatitis.A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD Pathophysiology guided treatment of nonalcoholic steatohepatitis Incretin based therapies: a novel treatment approach for non-alcoholic fatty liver disease Selection of the appropriate method for the assessment of insulin resistance Nonalcoholic fatty liver disease: new treatments Vitamin E and nonalcoholic fatty liver disease Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD): A PRISMA-compliant systematic review and network meta-analysis.Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.Insulin sensitizers in treatment of nonalcoholic fatty liver disease: Systematic review.Endpoints and clinical trial design for nonalcoholic steatohepatitis.Pathogenesis of non-alcoholic fatty liver disease.Does vitamin E improve the outcomes of pediatric nonalcoholic fatty liver disease? A systematic review and meta-analysis Mechanisms inactivating the gene for E-cadherin in sporadic gastric carcinomas.Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design.Treatment of nonalcoholic fatty liver disease in children: TONIC trial design.Treatment options for nonalcoholic Fatty liver disease Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis.Current status of therapy in nonalcoholic Fatty liver disease.PPAR gamma and human metabolic disease Metabolomic profiling to identify predictors of response to vitamin E for non-alcoholic steatohepatitis (NASH).Surgical treatment of nonalcoholic fatty liver disease in severely obese patients The use of selected nutrition supplements and complementary and alternative medicine in liver disease.Treatment of non-alcoholic fatty liver disease.Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease.Effects of α-tocopherol and β-carotene supplementation on liver cancer incidence and chronic liver disease mortality in the ATBC study The role of insulin-sensitizing agents in the treatment of nonalcoholic steatohepatitis.Glitazones for human nonalcoholic steatohepatitis Mechanisms and implications of age-related changes in the liver: nonalcoholic Fatty liver disease in the elderly.Possible role of tocopherols in the modulation of host microRNA with potential antiviral activity in patients with hepatitis B virus-related persistent infection: a systematic review.Non-alcoholic fatty liver disease: The diagnosis and management.Role of vitamins in gastrointestinal diseases.

P2860

Q24197984-E2F36090-4A54-4934-B6B6-4DBABFE415D7 Q24200256-34B06D9B-3FF2-4CF8-A14C-F030D8B32CA1 Q24236298-D5EDD7D1-FDCD-4C55-B5C4-467035047162 Q24243125-78E880DA-1C62-4A88-A3AE-46BB20B64EFE Q24246447-EAEA306C-F31E-4746-ABC4-08C51E72EB75 Q24625697-C5219DAF-025F-483B-A591-6CC6464BB724 Q24649618-C89DAABD-78FF-4FBA-BF58-55F13B5FB09E Q24655572-F67DB7D3-A29B-4B20-BA9D-2CCD36553684 Q24815160-AA85EFE5-EA03-4634-BDF2-6630316F33EF Q26752487-906DC6EE-21DC-43B7-A024-D72777EFA02D Q26827117-CD088D2A-0C23-463C-9710-703B33485593 Q26827183-E60CFC92-7B53-4773-9922-7310C89D0975 Q27001024-F03AE88C-ADC9-4645-BCE4-DA20279D38B3 Q27021161-784FC820-1B6E-4912-A3B9-8A2EC18645AF Q27693883-74DC64F7-4231-41FD-B5BE-80C678E1695B Q30248535-D308F682-6404-474E-BA13-F6FD6AB36473 Q30389752-437F8509-018F-4C97-AFC7-E2852C3902CC Q33268183-2EB97349-62FF-4CD1-BE25-A3767DC28D82 Q33583798-F1AC06BF-161E-45B9-8B9E-7CD1CD0D1EE1 Q33606303-F3C3C0FA-0C53-4EAD-BA9D-07FB2D7E4080 Q33796012-93D0DC3B-594A-48AC-B7BD-703D18749AF5 Q33867088-3051DF42-AAF6-4BEC-ADDA-051CCEDE561D Q34090872-92C1EC60-A530-47C8-B2C1-354520D65179 Q34114795-9BE8507C-49DD-44D6-AFD0-1CE413C46E68 Q34156317-F7A3EEF5-8CE1-4EA9-A36E-4626671713BD Q34344465-0E1F1E9A-8914-46F1-A8C5-0EFBC76F8264 Q34408961-9F30ED86-C0A5-4A32-AB47-61BC4A9356E1 Q34416432-509E0020-55CC-458B-A887-48D52A575151 Q34426919-ACA34413-B489-4927-83E5-E4DC84C84F1D Q34446294-D6595F95-9B0C-4A65-B02C-1EBB9D861678 Q34554574-1E5BFF1E-7CBF-4609-B326-02E9E5A6357E Q34592654-7D0463A0-C560-424B-8C15-F7E92FB2854B Q34647400-EF4AF021-4151-46C0-9A17-37EF189B79DE Q34687005-045DEFB3-7718-4B81-BCB5-75B0052F6E39 Q35090416-F6958A92-5071-4982-B180-4647BFF2C05A Q35191067-14991B35-D7E6-46D9-AEEF-14C349570842 Q35209849-989C0643-B0C8-40D9-A0B4-7D5CBABD4C82 Q35343911-5693AA12-B7B4-4529-A398-B9A4B9FEAEC0 Q35543956-2F68ABDD-1917-4EF8-885F-34C2658151CE Q35567624-886EA56F-09D9-4762-ACE8-21978C652D31

P2860

A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis.

http://www.wikidata.org/entity/Q44907394

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

A pilot study of vitamin E ver ...... nonalcoholic steatohepatitis.

@en

A pilot study of vitamin E ver ...... nonalcoholic steatohepatitis.

@nl

type

label

A pilot study of vitamin E ver ...... nonalcoholic steatohepatitis.

@en

A pilot study of vitamin E ver ...... nonalcoholic steatohepatitis.

@nl

prefLabel

A pilot study of vitamin E ver ...... nonalcoholic steatohepatitis.

@en

A pilot study of vitamin E ver ...... nonalcoholic steatohepatitis.

@nl

P1433

Q44907394-381D05E5-DF14-4CB8-997F-E5AFB27AE6FF

P1476

Q44907394-0AB1EF3D-C737-4C90-AF57-48E5095B4CB0

P2093

Q44907394-029FF80A-5CFD-46FB-A006-4327B7E7C165

Q44907394-0B14D22A-11CE-4612-912D-75C82A74F44F

Q44907394-21FF063B-7AB4-468C-AF59-97679E52ACC3

Q44907394-58A8C92D-4408-4EA8-A94C-BF4C475FC5D3

Q44907394-926AC00A-36DB-430F-B002-4FA0A2D30FAF

Q44907394-93FE76BE-5BF0-4C42-8828-17B46931DDD0

Q44907394-97FF3BAF-ECB4-4C10-AECE-9045B64106EE

Q44907394-B1375966-EB54-4ECA-803A-7167E95BFA3E

Q44907394-BEAF45C6-6E3D-4563-8668-AD5FF035EB5F

Q44907394-E88276AD-F625-4C0F-BE26-A91A3FE48AC3

P304

Q44907394-254BE4C0-3C2D-4B08-9AB9-00D2CDCC50EB

P31

Q44907394-69EBC1C3-BB7B-4266-AC93-9B467A4E493E

P356

Q44907394-0823BBEA-4EF1-4F4A-89B5-CFA2D14749B9

P407

Q44907394-BA565040-2E9F-4849-BC77-CF16E910F15C

P433

Q44907394-9F916547-AC13-40DB-809B-E1E8AB47BBDA

P478

Q44907394-C222D82A-42C6-4ADD-B157-5AFD8AF316CF

P577

Q44907394-62EFDD32-0B7B-4104-88CE-524ED662B9CE

P698

Q44907394-1F8EF474-46FF-4C28-AFF8-047B35466107

P921

Q44907394-532cb24f-9f17-48b7-837c-38c15768a65b

Q44907394-587E9A3C-48EF-4DCD-B13D-5C41FDFBB265

P356

S1542-3565(04)00457-4

P1433

Clinical Gastroenterology and Hepatology

P1476

A pilot study of vitamin E ver ...... nonalcoholic steatohepatitis.

@en

P2093

Alan S Mills

http://www.w3.org/2001/XMLSchema#string

Arun J Sanyal

http://www.w3.org/2001/XMLSchema#string

Carol Sargeant

http://www.w3.org/2001/XMLSchema#string

John Clore

http://www.w3.org/2001/XMLSchema#string

Melissa J Contos

http://www.w3.org/2001/XMLSchema#string

Mitchell L Shiffman

http://www.w3.org/2001/XMLSchema#string

Pouneh S Mofrad

http://www.w3.org/2001/XMLSchema#string

R Todd Stravitz

http://www.w3.org/2001/XMLSchema#string

Richard K Sterling

http://www.w3.org/2001/XMLSchema#string

Velimir A Luketic

http://www.w3.org/2001/XMLSchema#string

P304

1107-1115

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1542-3565(04)00457-4

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2004-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15625656

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis